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012.08.0Abstract Background: No data are available about plasma lipid proﬁle in Egyptians with coro-
nary artery disease (CAD). Plasma lipid proﬁle may differ according to ethnic origin and geo-
graphic area.
Objectives: Identify plasma lipid abnormalities in Egyptians with CAD and deﬁne the role of age,
type of CAD, and the presence of hypertension (HT) on lipid proﬁle.
Methods: Retrospective consecutive sampling of lipid proﬁle of 1000 patients with CAD. Results
were compared to a control group of 1920 non-coronary individuals.
Results: Patients’ age range was 19–90 years. HT was present in 56.7% of patients. The commonest
isolated lipid abnormality was a reduced HDL-C in men and increased plasma triglycerides (TG) in
women. Patients with myocardial infarction (MI) had a lower HDL-C than those with angina pec-
toris (AP). Abnormalities were more severe and more prevalent in the young age group. No signif-
icant difference in lipid proﬁle was present between normotensive (NT) and hypertensive (HT)
CAD patients.
Conclusion: Dyslipidemia is common among Egyptians with CAD. Lipid proﬁle was inﬂuenced by
age, gender, type of CAD, but not by the presence of HT. The high prevalence rate of risk factors
particularly among young Egyptians is remarkable and can explain the epidemic of CAD among
Egyptians.
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051. Introduction
It is projected that CAD will be the leading cause of death in
developing countries by the year 2020.1,2 In Egypt, mortality
secondary to CAD is rapidly rising. According to WHO statis-
tics3 the age-standardized mortality rates from CAD are one of
the highest worldwide. One possible explanation is the high
prevalence rate of CAD risk factors. Hypertension, dyslipide-
mia and obesity are common among Egyptians.4 Unfortu-
nately, systematically documented data on CAD prevalence,g by Elsevier B.V. All rights reserved.
80 M. Mohsen Ibrahim et al.incidence and rate of cardiovascular risk factors in developing
countries are scarce.5,6 There is geographic and genetic vari-
ability in the prevalence of CV risk factors and in their contri-
bution to the development of CAD.7,8 When investigating the
relationship between CAD and lipid disturbances it is neces-
sary to use local data on blood lipid proﬁle in each region.
The prevalence, type of lipid abnormalities and its association
with CAD were not reported among Egyptians. Knowledge
about the determinants of disease in persons within popula-
tions and of lipid proﬁle in this group of relatively high-risk
patients could be used to make recommendations on lipid
management. Prevention programs will give priority to the
most common risk factors and possibly the predominant type
of dyslipidemia.
The present study has two objectives. First: to deﬁne the li-
pid proﬁle in Egyptian patients with CAD who are not on li-
pid-lowering therapy. Second: to examine the effects of age,
gender, type of CAD and the presence of hypertension on
changes in lipid proﬁle.
2. Methods
The study design was a retrospective consecutive sampling of
all patients with CAD who satisﬁed the inclusion criteria.
The data were collected from specialized cardiac clinic records
during the period 1998–2006. Included in the study were pa-
tients with complete records showing detailed lipid proﬁles
on 12 h fasting plasma samples who had a diagnosis of chronic
stable angina or remote (at least 3 months) myocardial infarc-
tion and were not receiving statins or lipid lowering drugs on
their initial clinic visit.
Plasma concentrations of total cholesterol and triglycerides
were determined by enzymatic methods (Boehringer–Mann-
heim). HDL cholesterol was measured after precipitations of
VLDL and LDL by the phosphotungstate method (Boehrin-
ger–Mannheim). LDL was estimated using the Friedwald for-
mula when TG levels did not exceed 300 mg/dl and otherwise
using direct quantitative homogenous enzymatic assays.
3. Control subjects
Data were collected during the Egyptian National Hyperten-
sion project (NHP), a national hypertension survey in Egypt.
NHP was a multistage, national survey conducted between
1991 and 1993. The design and rationale of the NHP have been
reported.4,9,10 The survey consisted of two phases. During
phase I of the survey, hypertensive (HT) patients were identi-
ﬁed. In phase II, clinical and laboratory evaluations were made
on HT and gender matched normotensive (NT). A total of
2313 individuals were examined. After exclusion of CAD pa-
tients, there were 1920 patients with complete laboratory and
clinical data, 716 were normotensive and 1404 hypertensive.
Blood was collected after 12 h of fasting. Samples were pro-
cessed locally, frozen at 30 C and then transferred to the ba-
sic central laboratory for batch analysis.
4. Ethics
No information that could identify a subject directly or indi-
rectly was requested. Ethical approval of the study was, there-
fore, not required.5. Deﬁnitions
High blood pressure (BP) was diagnosed based on at least two
separate clinic visits (average of the last two of the 3 measure-
ments during each visit) if mean SBP was P140 mmHg or
DBP P90 mmHg or if patients were receiving treatment for
hypertension.
5.1. Chronic stable angina
Classic history of typical anginal pain with evidence of myo-
cardial ischemia on stress testing or an abnormal coronary
angiogram.5.2. Myocardial infarction
History and results of hospital records (ECG changes and ele-
vated cardiac enzymes) or history and ECG changes showing
pathologic Q waves. Only patients with remote MI (at least
3 months) were included in the study.
5.3. Overweight
Overweight was deﬁned as BMI between 25–29.9 kg/m2. Obes-
ity, deﬁned asP 30 kg/m.25.4. Dyslipidemia
Three different cutpoints were used to analyze the prevalence
of high LDL-C and low HDL-C based on the different existing
consensus recommendations. The selected cutpoints for high
LDL-C were 100, 130 and 160 mg/dl and for low HDL were
35, 40 and 50 mg/dl. Cutpoint used to analyze prevalence of
hypertriglyceridemia was (>150 mg/dl). A total plasma cho-
lesterol level P200 mg/dl was considered abnormal.
Diabetes mellitus was diagnosed if fasting plasma glucose
was P126 mg/dl on two laboratory results or if the patient
was on antihyperglycemic therapy.6. Statistical analysis
The following data were entered into a computer program with
SPSS statistical package for detailed statistical analysis:
(1) Demographic characteristics: age and gender.
(2) Lipid proﬁle: total cholesterol (TC), LDL-C, HDL-C,
triglycerides and TC/HDL-C ratio.
(3) BMI.
(4) Hypertension state.
Mean values were reported for continuous variables. Prev-
alence and frequencies are expressed in terms of percentage.
Comparison between groups was performed using the chi-
squared test to compare frequencies, the student t-test to com-
pare mean values of the 2 groups.
Results were classiﬁed into 3 age groups for normotensive
(NT) and hypertensive (HT) subjects and for men and women
when the numbers in each gender type were adequate.
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A thousand consecutive patients with CAD satisﬁed the inclu-
sion criteria. The results were compared with ﬁndings in 716
NT and 1404 HT subjects without coronary disease who
served as a control group.
7.1. Population Characteristics
The age of the patients ranged from 19–90 years old with a
mean age of 54 years, 77.6% of the patients were males, 543
patients had stable CAD (angina-AP) while 457 had a history
of myocardial infarction (MI). Hypertension was present in
56.7% of patients, obesity (BMIP 30 kg/m2) in 25.8%, and
diabetes mellitus in 34.4%.
7.2. Prevalence of lipid abnormalities in patients with CAD
Mean values (mg/dl) for LDL-C, HDL-C, TC and triglycer-
ides (TG) were 140.6, 41.5, 217, and 160.9, respectively. Low
HDL-C (<40 mg/dl) was present in 49.2% of CAD patients,
increased LDL-C (>160 mg/dl) in 30.2%, increased triglycer-
ides (>150 mg/dl) were present in 45% of patients. The pat-
tern of lipid abnormalities differed according to gender
(Fig. 1) and type of CAD. In males, the most frequent abnor-
mality was a low HDL-C (55.4%). In females, the commonest
abnormality was increased LDL-C (41.1%). Fig. 2 is a pie
chart showing the distribution of isolated and combined lipid
abnormalities in CAD patients for men and women. Table 1
shows the prevalence of lipid abnormalities at different cutoff
points.
Patients with MI had a lower level of HDL-C (HDL-
C< 40 mg/dl) than AP patients (62.2% versus 40%,
respectively). Females with MI have the highest prevalence
rate of increased LDL-C present in 51.7%. Male patients with
MI have the highest rates of increased TG (49.4%). When
cutoff points for low HDL-C were based upon the National
Cholesterol Education Program (<40 mg/dl for men and
<50 mg/dl for women) 55.4% of male patients and 65.6%
of female patients had abnormal low HDL-C.
Among patients with CAD, a completely normal blood li-
pid proﬁle was present in 20.2% of male patients and 29.9%
of females. Low HDL-C (<40 mg/dl) as the only lipid abnor-
mality was present in 21.4% of males and 7.6% of females. In-Figure 1 Frequency of lipid abnormalities in Egyptian men and
women with CAD.creased LDL-C > 100 mg/dl was present in more than 80% of
patients. Low HDL-C with normal LDL-C was present in
34.6% of CAD patients.
7.3. Effect of age
Table 2 shows the lipid proﬁle of CAD patients in the three age
groups. Plasma levels of TC, LDL-C and TG were higher in
the young compared to middle age and elderly patients. There
was a trend for a decrease in plasma levels with advancing age.
There was no difference in the prevalence of hypertriglycerde-
mia and very low HDL-C (<35 mg/dl) between the 3 age
groups. TC/HDL-C ratio was higher in the young compared
to the middle age group. Obesity was more prevalent in young
CAD patients than in middle age and elderly patients.
7.4. Comparison of NT and HT CAD patients
Table 3 shows a comparison of plasma lipids, prevalence of
obesity and diabetes in normotensive and hypertensive CAD
patients. Hypertensive patients were older than normotensive
patients. There were no signiﬁcant differences between the
two groups as a whole in plasma lipid levels. The only signiﬁ-
cant difference between normotensive and hypertensive pa-
tients was in the TG levels which were higher in young
hypertensive patients and in LDL-C levels which were higher
in elderly hypertensives. A higher prevalence of low HDL-C
(635 mg/dl) was present among the young hypertensives.
There was a tendency of a higher TC/HDL-C ratio among
hypertensive patients. Obesity was more common in middle
age hypertensives. Prevalence of diabetes did not differ be-
tween NT and HT CAD patients.
7.5. Comparison of NT CAD patients and NT controls
In all age groups, levels of plasma TC, LDL-C and TG were
higher in NT CAD patients compared to the NT controls.
Prevalence of abnormalities in lipid levels (increased TC,
LDL-C and TG) was signiﬁcantly greater only in young and
middle age groups. Plasma low HDL-C level and its prevalence
were higher only in middle age patients. Diabetes was more
prevalent in all age groups of CAD patients. Obesity was more
common in the middle age control group than in CAD pa-
tients. Table 4 shows lipid abnormalities and prevalence of dia-
betes and obesity in normotensive CAD patients and
normotensive control subjects at different age groups.
Advancing age was associated with a tendency to increased
LDL-C plasma levels in normal subjects while the reverse was
present in CAD patients. Fig. 3 shows that the trend in normo-
tensive controls was an increase in LDL-C (P160 mg/dl) till
the age of 60 years; while the reverse was present in CAD pa-
tients. Also, there was a trend for lower TG levels with advanc-
ing age in CAD patients. HDL-C plasma levels were not
inﬂuenced by age in controls and CAD patients.
8. Discussion
This is the ﬁrst report of plasma lipid proﬁle among Egyptian
patients with CAD. It is one of the few studies in a developing
country involving a large number of CAD patients over a wide
age range. The effects of type of CAD, MI vs. AP, age, gender,
Figure 2 Frequency of isolated and combined lipid abnormalities in Egyptian men and women with CAD.
Table 1 Prevalence (%) of lipid abnormalities in 1000 CAD patients.
No. TC
(>200 mg/dl)
TG
(>150 mg/dl)
LDL
(>160 mg/dl)
LDL
(>130 mg/dl)
LDL
(>100 mg/dl)
HDL
(<35 mg/dl)
HDL
(<40 mg/dl) Males
HDL
(<50 mg/dl)
females
Total 1000 58.7 45.0 30.2 54.5 82.4 28.9 – –
M. 776 55.3 46.3 27.1 51.8 81.4 33.1 55.4 –
F. 224 70.5 40.6 41.1 63.8 85.7 14.3 – 65.6
HT. 567 61.6 47.4 31.2 56.1 83.1 29.1 56.4 64.2
NT. 433 55 41.8 28.9 52.4 81.5 28.6 54.3 69.2
MI 457 57.5 48.8 32.2 55.8 81.4 36.8 – –
AP 543 59.7 41.8 28.5 53.4 83.2 22.3 – –
MI M. 399 55.9 49.4 29.3 53.6 80.7 38.3 62.4
MI F. 58 70 44.8 51.7 70.7 86.2 25.9 – 77.6
AP M. 377 54.6 42.9 24.7 49.9 82.2 27.6 48
AP F. 166 71.1 39.2 37.3 61.4 85.5 10.2 – 61.4
DM. 344 59.6 48.3 30.2 54.7 82.3 29.9 58.2 65.3
Obesity 522 65.3 51.2 32.6 59.7 85.2 27.1 58.8 62.6
M: males F: females.
MI: myocardial infarction AP: stable angina pectoris.
DM: diabetes mellitus Obesity: BMIP 30 kg/m2.
82 M. Mohsen Ibrahim et al.high BP and body weight are described. The fact that only a
minority of Egyptian CAD patients receive statin therapy11 al-
lowed the recruitment of a large number of patients not on li-
pid modifying therapy. The results were compared to a control
population of normotensive and hypertensive Egyptians with-
out CAD in the same age groups. The commonest isolated li-
pid abnormality was a reduced HDL-C in men (21.4%) and
increased plasma TG (>150 mg/dl) in women (15.2%). A
completely normal plasma lipid proﬁle was present in 20.2%
of male and 29.9% of female patients.
The overall prevalence of dyslipidemia in our CAD patients
was greater than previously reported.12–15 Mohan et al. 16
found no difference in mean HDL-C levels between CAD
and non CAD Asian Indians. On the other hand, Rubins
et al. 17 while comparing their population with CAD with
the general US men found a striking difference between the
2 populations in all age groups, lower levels of HDL-C and
higher level of TG in men with CAD. Ethnic differences, die-
tary habits and lifestyle may explain differences between differ-
ent populations.A low HDL-C (<35 mg/dl) was reported in 38% of CAD
male patients,15 while HDL-C < 40 mg/dl was present in
49% of our CAD patients and in 45% of Jordanian CAD pa-
tients.14 Data from a number of epidemiologic studies showed
that low HDL-C is not uncommon in the general popula-
tion.17–20 A high prevalence of low HDL-C (<35 mg/dl) was
present in normotensive Egyptian men and women (32.2%
and 20.6%, respectively).4
Increased triglycerides (>150 mg/dl) were present in 45%
of our CAD patients while it ranged between 23% and
44.5% in control subjects depending upon age, presence or ab-
sence of hypertension. Other studies from our region found
that CAD patients had signiﬁcantly higher TG and TC and
lower HDL-C levels than individuals with no CAD.14,21
Our young CAD patients (<40 years) had higher preva-
lence of plasma lipid abnormalities compared to middle age
and elderly patients. The tendency for increased LDL-C with
advancing age in our control group and previously reported
in normal subjects4,22,23 was not present and even reversed
in our CAD patients. Aging appeared to attenuate the
Table 2 Lipid proﬁle in the three age groups.
P
Age (years) <40 40–60 >60 (1) vs (2) (2) vs (3) (1) vs (3)
(1) (2) (3)
No. 62 674 264
TC (mg/dl) 231.0 217.8 213.4 0.05 0.2 0.01
LDL-C (mg/dl) 152.8 141.4 135.8 0.04 0.07 0.005
HDL-C (mg/dl) 41.5 40.5 43.8 0.4 0.000 0.1
TG (mg/dl) 178.5 163.3 150.8 0.1 0.02 0.004
›TC (>200 mg/dl) (%) 71 60.4 58.2 0.3 0.3 0.04
›LDL-C (%)
>100 (mg/dl) 88.9 83.7 76.9 0.1 0.6 0.08
>130 (mg/dl) 72.6 54.7 49.6 0.9 0.7 0.001
>160 (mg/dl) 40.3 30.4 27.3 0.1 0.1 0.03
Low HDL-C (%)
<35 (mg/dl) 27.4 32.6 19.7 0.4 0.6 0.4
<40 (mg/dl) 45.2 53.0 40.5 0.5 0.06 0.1
<50 (mg/dl) 80.6 83.2 73.9 0.2 0.001 0.5
›TG (%)
>150 (mg/dl) 45.2 53.7 60.6 0.2 0.3 0.7
TC/HDL-C 5.8 5.6 5.0 0.5 0.000 0.001
›BMI (P30 kg/m2)% 21.0 12.9 11.0 0.02 0.02 0.01
Table 3 Comparison of NT and HT CAD patients at different age groups.
Age All <40 40–60 >60
NT HT P NT HT P NT HT P NT HT P
No. 433 567 39 23 309 365 85 179
Age mean 51.96 55.78 <0.001 35.1 34.9 0.8 49.9 51.7 0.000 66.9 66.8 0.9
TC (mg/dl) 214.45 219.78 0.09 231.9 229.5 0.8 213.9 221.1 0.06 208.4 215.7 0.2
LDL-C (mg/dl) 138.84 141.99 0.2 143.2 145.9 0.6 139.6 143.8 0.1 134.1 144.4 0.05
HDL-C (mg/dl) 41.20 41.68 0.4 43.6 41.8 0.2 39.8 42.0 0.01 41.8 40.8 0.1
TG (mg/dl) 156.49 164.38 0.1 146.3 170.0 0.01 163.9 162.4 0.8 150.6 164.3 0.09
›TC(>200 mg/dl)(%) 57.3 63.1 0.06 69.2 73.9 0.4 56.6 63.6 0.04 54.1 60.9 0.1
›LDL-C (%)
P100 mg/dl 81.5 82.7 0.3 89.7 87.0 0.5 81.2 85.8 0.07 78.8 76.0 0.3
P130 mg/dl 52.4 56.1 0.1 71.8 73.9 0.5 52.8 56.4 0.1 42.4 53.1 0.06
P160 mg/dl 28.9 31.2 0.2 35.2 36.7 0.4 30.5 29.0 0.3 21.3 31.8 0.03
LOW HDL-C (%)
<35 mg/dl 28.6 29.1 0.8 18.7 30.3 0.04 33.6 28.4 0.1 27.0 29.7 0.3
<40 mg/dl 50.3 48.3 0.2 43.6 47.8 0.4 52.4 53.4 0.4 45.9 38.0 0.1
<50 mg/dl 83.1 78.7 0.07 79.5 82.6 0.5 85.1 81.6 0.1 77.6 72.1 0.2
›TG(%)
P150 mg/dl 41.8 47.4 0.07 64.8 47.7 0.01 55.5 53.9 0.3 58.2 53.4 0.2
TC/HDL-C 5.4 5.5 0.3 5.3 5.7 0.06 5.6 5.4 0.2 5.3 5.6 0.08
Diabetes (%) 30.9 37.0 0.04 28.6 33.0 0.3 28.6 38.4 0.1 36.9 37.0 0.5
BMI (kg/m2) 25.4 25.9 0.1 25.5 26.2 0.5 25.1 26.3 0.000 26.2 25.1 0.3
›BMI(P30 kg/m2)% 12.0 13.4 0.06 15.4 13.8 0.7 10.5 15.2 0.01 13.1 9.5 0.5
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Chodorwski et al. 24 found in patients with acute MI a de-
cline in LDL-C until the age of 68, HDL-C levels did not
change with age. Even though total cholesterol concentration
represents a signiﬁcant risk factor in the elderly, there is evi-
dence that this relationship weakens progressively with
advancing age to the point where TC levels do not appearto contribute to the risk of CAD or overall mortality beyond
the age of 70 years.25,26
Abnormalities in plasma lipids and blood sugar were re-
ported to be more frequent in hypertensive patients compared
to normotensives.4,20,27 This was not present in our CAD pa-
tients except for higher TG levels in young and higher LDL-
C in elderly hypertensive patients. Hammoudah et al. found
Table 4 Comparison of lipid proﬁle in normotensive CAD and normotensive controls.
<40 40–60 >60
CAD Controls P CAD Controls P CAD Controls P
No. 39 299 309 341 85 76
Age mean 35.1 32.1 0.000 49.9 48.2 0.000 66.9 67.6 0.4
TC (mg/dl) 231.9 175.7 0.000 213.9 191.1 0.000 208.4 190.05 0.009
LDL (mg/dl) 156.6 109.8 0.000 138.6 120.6 0.000 131.6 121.9 0.1
HDL (mg/dl) 42.3 42.3 0.9 40.6 42.0 0.04 43.1 42.5 0.4
TG (mg/dl) 160.4 118.9 0.000 158.8 145.2 0.01 146.2 127.2 0.03
› TC (> 200 mg/dl) (%) 69.2 22.6 0.000 56.6 36.4 0.000 54.1 37.8 0.02
› LDL-C (%)
P100 (mg/dl) 89.7 62.0 0.000 81.2 68.9 0.000 78.8 79.5 0.5
P130 (mg/dl) 71.8 24.7 0.000 52.8 36.9 0.000 42.4 42.5 0.5
P160 (mg/dl) 43.6 6.2 0.000 28.5 13.8 0.000 23.5 11.0 0.03
Low HDL-C (%)
<35 (mg/dl) 23.1 24.6 0.5 31.1 26.2 0.07 22.4 25.7 0.2
<40 (mg/dl) 43.6 42.7 0.5 52.4 44.9 0.02 45.9 43.2 0.5
<50 (mg/dl) 79.5 76.1 0.3 85.1 76.5 0.003 77.6 67.6 0.1
› TG (%)
P150 (mg/dl) 56.4 20.3 0.000 57.9 35.5 0.000 60.0 23.0 0.000
TC/HDL-C 5.7 4.4 0.000 5.5 4.8 0.000 5.1 4.7 0.2
Diabetes (%) 12.8 3.8 0.02 32.0 8.5 0.000 35.3 12.2 0.000
BMI (kg/m2) 25.5 27.7 0.03 25.1 28.4 0.000 26.2 26.0 0.8
›BMI (P30 kg/m2)% 23.1 23.7 0.9 10.7 30.1 0.000 11.8 19.5 0.3
Figure 3 Prevalence of increased LDL-C(P160 andP100 mg/dl)
in NT CADs and NT controls in different age decades.
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sible that lipid abnormalities present in CAD patients mask the
difference between normotensive and hypertensive subjects.
A comparison of normotensive CAD and normotensive
controls in the same age group showed signiﬁcant differences
in plasma lipid abnormalities of TC, LDL-C and TG which
were more prevalent in CAD patients. Diabetes was more than
3 times frequent in normotensive CAD patients compared to
normotensive controls in the same age group, while there
was no difference in the prevalence of diabetes between normo-
tensive and hypertensive CAD patients.
The prevalence of obesity in our normotensive subjects was
greater in the control group than CAD patients particularly in
the middle age. This was an unexpected observation, since obes-
ity is considered an independent risk factor for CAD28 and was
associated with more frequent lipid abnormalities. One expla-
nation is the type of body fat distribution, since visceral abdom-inal obesity is the one associated with increased
cardiometabolic risk.29 Information about waist circumference
and type of obesity-visceral vs. subcutaneous is not available in
our study.
We found difference in lipid proﬁle between MI and AP pa-
tients, which was gender dependent. In general, patients with
MI had a lower level of HDL-C than AP patients. ACS in Jor-
danian patients had lower total cholesterol, triglycerides and
LDL-C levels compared with those with chronic CAD.14
The study population was recruited from a single cardiac
referral center. Therefore, the data are not representative of
the whole nation and are liable to selection bias. Because of
the relatively large number and inclusion of both genders over
a wide age spectrum they possibly represent a large segment of
the Egyptian CAD patients. The absence of information about
other risk factors e.g. cigarette smoking might have inﬂuenced
some of the results. Angiographic documentation of CAD was
not available in all patients. The use of different cutoff points
diagnostic of lipid abnormalities, though confusing, makes
possible a comparison of our prevalence data with other re-
ported studies which use different diagnostic thresholds.
9. Conclusion
This is the ﬁrst report of plasma lipid abnormalities in Egyp-
tians with CAD. Lipid abnormalities were present in about
80% of patients. The type of plasma lipid abnormality differed
according to age, gender and mode of presentation of CAD,
while the presence of hypertension had a limited effect on
the changes in lipid proﬁle. Dyslipidemia was especially com-
mon among young CAD patients and with aging the preva-
lence of lipid abnormalities was gradually attenuated.
This high prevalence of plasma lipid abnormalities in our
Egyptian patients underscores the need for a nationwide public
Lipid proﬁle in Egyptian patients with coronary artery disease 85awareness campaign promoting healthy diet and physical
activity. Routine screening in high risk groups for dyslipidemia
and other risk factors should be encouraged.Acknowledgments
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